UnitedHealth tops Q2 EPS and raises FY26 guidance on CNBC
UnitedHealth Group reports adjusted Q2 EPS of $6.38 and GAAP EPS of $6.04, with revenue $112.03B, and issues FY26 guidance above estimates on CNBC’s Final Trades.
On CNBC’s “ Halftime Report Final Trades,” Stephen Weiss, chief investment officer and managing partner of Short Hills Capital Partners, picked UnitedHealth Group Inc (NYSE: UNH ).
Lending support to his choice, UnitedHealth Group, on July 16, reported better-than-expected second-quarter financial results and issued FY26 guidance above estimates.
Adjusted earnings came in at $6.38 per share, topping the analyst consensus estimate of $4.86.
Revenue increased to $112.03 billion from $111.62 billion a year earlier and exceeded Wall Street expectations of $110.83 billion.
GAAP earnings were $6.04 per share.
Kevin Simpson, Capital Wealth Planning CEO, named Visa Inc (NYSE: V ) as his final trade.
Visa, on July 28, reported quarterly earnings of $3.32 per share, which beat the consensus estimate of $3.23, according to Pro data.
Quarterly revenue came in at $11.63 billion, just ahead of the Street estimate of $11.39 billion.
Don’t forget to check out our premarket coverage here Jim Lebenthal, partner and chief market strategist at Cerity Partners, recommended Lockheed Martin Corp (NYSE: LMT ).
Supporting his view, Citigroup analyst John Godyn, on Aug.
13, maintained a Buy on Lockheed Martin and raised the price target from $641 to $691.
Price Action: UnitedHealth shares gained 0.7% to close at $401.73 on Friday.
Visa shares fell 0.4% to settle at $364.15 during the session.
Lockheed Martin shares rose 1.8% to close at $608.68 on Friday.
Photo via Shutterstock